Skip to main content

Table 1 Baseline study characteristics (n = 3522, aged 18–97 years).

From: Patients' opinion on the barriers to diabetes control in areas of conflicts: The Iraqi example

Variables

HbA1C < 7% n = 835(%)

HbA1C ≥ 7 n = 2688 (%)

Total No (%)

P value

Gender

Men

383 (22.8)

1299 (77.2)

1676(47.6)

0.282

 

Women

442 (24.3)

1374 (75.7)

1816 (51.5)

 

Age

55.14 ± 12.96

53.35 ± 12.73

53.78 ± 12.81

0.622

Smoker

141 (19.4)

585 (80.6)

726(20.6)

0.002

Qualification

5.31 ± 5.80

5.01 ± 5.63

5.08 ± 5.67

0.401

Address

Urban

518 (24.2)

1624 (75.8)

2142(60.8)

0.408

 

Rural

317 (23.0)

1063 (77.0)

1380(39.2)

 

Weight -kg-(mean ± SD)

76.84 ± 16.32

75.79 ± 17.12

76.04 ± 16.94

0.122

Waist -cm-(mean ± SD)

98.96 ± 12.4

98.3 ± 13.0

98.4 ± 12.9

0.371

BMI

28.09 ± 5.55

27.53 ± 5.62

27.6 ± 5.6

0.988

Waist-hip ratio (mean ± SD)

0.94 ± 0.06

0.94 ± 0.07

0.94 ± .07

0.030

Waist-to-height ratio (mean ± SD)

0.59 ± 0.07

0.59 ± .08

0.59 ± .08

0.903

Type of diabetes

Type 1 diabetes

11 (8.7)

116 (91.3)

127(3.6)

< 0.0001

 

Type 2 diabetes

824 (24.3)

2571(75.7)

3395(96.4)

 

Therapy

Oral *

744 (26.7)

2044 (73.3)

2788 (79.2)

< 0.0001

 

Insulin ± oral

91 (12.4)

643 (87.6)

734(20.8)

< 0.0001

Hypertension

277 (24.5)

855 (75.5)

1132(32.1)

0.471

Coronary heart disease

55 (21.7)

198 (78.3)

253 (7.2)

0.490

Cerebrovascular disease

44 (29.3)

106 (70.7)

150(4.3)

0.116

Proteinuria

48 (25.7)

139 (74.3)

187(5.3)

0.536

  1. * Oral including metformin was used for all except in few with high creatinine or type 1 diabetes.